Fulcrum Therapeutics
Price & Volume
Stats
See more52W Range | $2.86-$13.70 |
Market Cap | $234.6M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $81.6M |
Revenue Growth (YoY) | 8,990.9% |
Gross Profit (12 Mos) | -$70.4M |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • last year
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last year
Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences
Yahoo Finance • last year
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |
